Ted Okon Addresses Payment Reform in Oncology, Issues of 340B
Ted Okon, MBA, executive director of the Community Oncology Alliance, discusses what influence the new administration may have on payment reform in oncology and issues regarding the 340B drug pricing program.
Ted Okon Addresses Payment Reform in Oncology, Issues of 340B
Ted Okon, MBA, executive director of the Community Oncology Alliance, discusses what influence the new administration may have on payment reform in oncology and issues regarding the 340B drug pricing program.